BioSpace News Archive

Rhythm Pharmaceuticals and Novartis will present findings from the latest stages of clinical evaluation of new anti-obesity medications during a special late-breaking research forum titled “Emerging Pharmacological Anti-obesity Therapies.” The research forum is part of the 37th Annual Meeting of The Obesity Society at ObesityWeek®.

Alleges OncoSec Board Breached Fiduciary Duty by Agreeing to China Grand Takeover Proposal at Depressed Price with No Effort to Explore Alternative Transactions or Financing Sources

AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications, announced the publication of an article titled “Genomic, Proteomic, and Immunologic Associations with a Durable Complete Remission of Measurable Metastatic Melanoma Induced by a Patient-Specific Dendritic Cell Vaccine” in the journal Human Vaccines and Immunotherapeutics.

Personalis, Inc., a leader in advanced genomics for cancer, announced it will release its third quarter 2019 financial results after the market closes on Wednesday, November 13, 2019.

Therapy Brands is pleased to announce Vickie Westmark has joined the company as Chief Operating Officer.

Health Canada is advising Canadians that the following products may pose serious health risks.

RhoVac AB announces, 30th October 2019, that Mikael Ørum will leave the board and the chair of the board, Gunnar Gårdemyr, who was elected to the board in May 2018, takes over as the chairman of the board.